Key Takeaways
- • Blackstone has raised around EUR 13 billion for its fourth European Senior Direct Lending Fund, according to a Moneycontrol report citing Bloomberg published November 4, 2026.
- • The fund targets mid-market and upper-mid-market borrowers across Europe, extending Blackstone's private credit scale and fee income.
- • Brad Marshall, global head of private credit strategies at Blackstone Credit & Insurance, attributed the raise to investor confidence in private credit fundamentals.
- • The fund has taken lead-lender roles in transactions involving Catalyst Pharmaceuticals, Regnology and Odevo.
- • The raise comes despite 2026 pressure on private credit over redemptions, software exposure, loan quality and valuations.
Summary
Blackstone has raised around EUR 13 billion for its European direct-lending strategy, according to a report by Moneycontrol, which cited Bloomberg and was published on Wednesday, November 4, 2026. The firm has closed its fourth European Senior Direct Lending Fund, which targets mid-market and upper-mid-market borrowers, segments where companies typically seek financing outside traditional bank channels.
The fundraising adds to Blackstone's scale in private credit, a business that generates fee income and expands the firm's lending capacity. It also supports the firm's push for asset gathering and diversification beyond traditional buyout funds.
The raise comes as institutional investors continue to commit capital to large private-credit managers, even though the asset class has faced pressure in 2026. Moneycontrol reported concerns around redemption requests, software exposure, loan quality and private-asset valuations. Brad Marshall, global head of private credit strategies at Blackstone Credit & Insurance, said investors were focusing on fundamentals rather than short-term market noise and viewed the lending backdrop as more attractive.
According to the report, the fund has already taken lead-lender roles in transactions involving Catalyst Pharmaceuticals, German regulatory-software company Regnology and residential-property manager Odevo. These examples illustrate deployment across healthcare, software and property-related lending.
The exposure also keeps Blackstone tied to the central risks of private credit, including borrower quality, valuation discipline and the ability of lenders to manage defaults or investor withdrawals. Blackstone stock traded at 113.28 euros on Lang & Schwarz at 13:41 CET on Thursday, November 5, 2026, according to the publisher's quote data.
The fundraising adds to Blackstone's scale in private credit, a business that generates fee income and expands the firm's lending capacity. It also supports the firm's push for asset gathering and diversification beyond traditional buyout funds.
The raise comes as institutional investors continue to commit capital to large private-credit managers, even though the asset class has faced pressure in 2026. Moneycontrol reported concerns around redemption requests, software exposure, loan quality and private-asset valuations. Brad Marshall, global head of private credit strategies at Blackstone Credit & Insurance, said investors were focusing on fundamentals rather than short-term market noise and viewed the lending backdrop as more attractive.
According to the report, the fund has already taken lead-lender roles in transactions involving Catalyst Pharmaceuticals, German regulatory-software company Regnology and residential-property manager Odevo. These examples illustrate deployment across healthcare, software and property-related lending.
The exposure also keeps Blackstone tied to the central risks of private credit, including borrower quality, valuation discipline and the ability of lenders to manage defaults or investor withdrawals. Blackstone stock traded at 113.28 euros on Lang & Schwarz at 13:41 CET on Thursday, November 5, 2026, according to the publisher's quote data.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.